625 Participants Needed

Digital Health Coaching for Cancer Survivorship

(COACH Trial)

Recruiting at 6 trial locations
KJ
AB
AB
JL
Overseen ByJennifer Loftis, DNP
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Pack Health
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial examines whether digital health coaching can assist individuals who have completed their main cancer treatment. Participants will either begin six months of digital coaching immediately or wait six months before starting the program. Both groups will be monitored through health data and wearable devices. The trial aims to determine if digital coaching improves recovery and overall health outcomes. It is suitable for individuals who have completed primary cancer therapy within the past year, have metastatic cancer, and have access to a smartphone or tablet. As an unphased trial, this study offers participants a unique opportunity to contribute to innovative research that could enhance recovery and health outcomes for cancer survivors.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your medications, especially if they are part of your ongoing cancer treatment.

What prior data suggests that this digital health coaching program is safe for cancer survivors?

Research has shown that digital health coaching is generally safe for individuals who have completed cancer treatment. Studies have found these programs easy to use and free from serious side effects. Participants often find them beneficial for their health. Although specific negative effects lack extensive data, digital health coaching is considered low-risk. It primarily focuses on improving lifestyle habits, such as diet and exercise, with personalized support. This approach offers a safe option for enhancing well-being after cancer therapy.12345

Why are researchers excited about this trial?

Researchers are excited about this digital health coaching program for cancer survivors because it offers a personalized and accessible approach to managing life after cancer treatment. While traditional options often focus on clinical follow-ups and physical rehabilitation, this digital program leverages technology to provide tailored advice and support through wearable data and patient-reported outcomes. This method aims to empower patients by integrating health coaching into their daily lives, potentially improving quality of life and health outcomes more effectively than standard care alone.

What evidence suggests that digital health coaching is effective for cancer survivorship?

Research has shown that digital health coaching, which participants in this trial may receive, can benefit cancer survivors. One study found that it improved their quality of life and emotional well-being. Participants reported feeling more supported and motivated to maintain healthy habits. Another study found that digital health coaching helped cancer survivors return to work more successfully, indicating better overall functioning. While these results are encouraging, further research is needed to fully understand how digital health coaching affects long-term health for cancer survivors.23456

Who Is on the Research Team?

Alexi A. Wright, MD, MPH - Dana-Farber ...

Alexi A. Wright

Principal Investigator

Dana-Farber Cancer Institute

Kathrin Milbury | MD Anderson Cancer Center

Kathrin Milbury, MA,PHD

Principal Investigator

The University of Texas MD Anderson Cancer Center

MH

Marilyn Hammer, PhD

Principal Investigator

Dana-Farber Cancer Institute

EA

Elizabeth Arthur, PhD

Principal Investigator

Ohio State University

JK

Jessica L. Krok-Schoen, PhD

Principal Investigator

Ohio State University

RL

Robin Lally, PhD

Principal Investigator

The University of Nebraska

RS

Rachael Schmidt, DNP

Principal Investigator

Nebraska Medicine

DE

Debra E Lyon, PhD

Principal Investigator

University of Florida College of Nursing

AG

Anneliese Gonzalez, MD

Principal Investigator

UTHealth Houston McGovern Medical School

KF

Kristen Fessele, PhD

Principal Investigator

Memorial Sloan Kettering Cancer Center

Are You a Good Fit for This Trial?

This trial is for cancer survivors who've finished their primary therapy within the last year. Participants must be adults (18+), able to read and speak English, consent to join, follow the study schedule, use a smartphone or tablet, and wear a Fitbit. Excluded are those with cognitive impairments, less than 6 months life expectancy, conditions limiting physical activity, or active treatment for relapsed disease.

Inclusion Criteria

I finished my main cancer treatment less than a year ago and am now in follow-up or maintenance.
I have a smartphone or tablet for digital health coaching.
Can read and consent to participate in the trial;
See 3 more

Exclusion Criteria

Your doctor believes you may not live longer than 6 months.
I am currently receiving treatment for my cancer that has come back.
I am able to understand and interact with a digital health program.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Digital Health Coaching (Intervention Group)

Participants receive a 6-month digital health coaching program with weekly person-to-person calls and digital nudges.

6 months
Weekly virtual interactions

Monitoring (Control Group)

Participants are monitored via patient-reported outcomes, clinical data, and wearable data collection for 6 months.

6 months

Follow-up

Participants are monitored for safety and effectiveness after the intervention, including microbiome and PRO data collection.

6 months
Data collection at months 3, 6, 9, and 12

What Are the Treatments Tested in This Trial?

Interventions

  • Digital Health Coaching Program
  • Fitbit
Trial Overview The study tests a digital health coaching program alongside Fitbit monitoring in cancer survivors post-treatment. It's set up so half of the participants start with coaching right away and then switch to just monitoring after 6 months; the other half do it in reverse order. They'll also give fecal samples to check gut health changes.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Active Control
Group I: Wait List Control GroupExperimental Treatment2 Interventions
Group II: Intervention GroupExperimental Treatment2 Interventions
Group III: Household Healthy ParticipantsActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Pack Health

Lead Sponsor

Trials
6
Recruited
1,100+

The University of Texas Health Science Center, Houston

Collaborator

Trials
974
Recruited
361,000+

M.D. Anderson Cancer Center

Collaborator

Trials
3,107
Recruited
1,813,000+

Daiichi Sankyo

Industry Sponsor

Trials
443
Recruited
493,000+
Hiroyuki Okuzawa profile image

Hiroyuki Okuzawa

Daiichi Sankyo

Chief Executive Officer

Degree in Social Sciences from Hitotsubashi University

Yuki Abe profile image

Yuki Abe

Daiichi Sankyo

Chief Medical Officer since 2023

MD

University of Florida

Collaborator

Trials
1,428
Recruited
987,000+

Memorial Sloan Kettering Cancer Center

Collaborator

Trials
1,998
Recruited
602,000+

National Institute of Nursing Research (NINR)

Collaborator

Trials
623
Recruited
10,400,000+

Daiichi Sankyo, Inc.

Industry Sponsor

Trials
390
Recruited
442,000+
Yuki Abe profile image

Yuki Abe

Daiichi Sankyo, Inc.

Chief Medical Officer since 2022

MD

Hiroyuki Okuzawa profile image

Hiroyuki Okuzawa

Daiichi Sankyo, Inc.

Chief Executive Officer

Degree in Social Sciences from Hitotsubashi University

GlaxoSmithKline

Industry Sponsor

Trials
4,834
Recruited
8,389,000+
Headquarters
London, UK
Known For
Vaccines & Medicines
Top Products
**Advair (salmeterol, fluticasone propionate)**, **Shingrix (shingles vaccine)**, **Augmentin (amoxicillin/clavulanate potassium)**, **Ventolin (salbutamol sulfate)
Dame Emma Walmsley profile image

Dame Emma Walmsley

GlaxoSmithKline

Chief Executive Officer since 2017

MA in Classics and Modern Languages from Oxford University

Dr. Hal Barron profile image

Dr. Hal Barron

GlaxoSmithKline

Chief Medical Officer since 2018

MD from Harvard Medical School

Dana-Farber Cancer Institute

Collaborator

Trials
1,128
Recruited
382,000+

Published Research Related to This Trial

A pilot study involving 88 men with prostate cancer demonstrated that a 12-week digital health coaching program was feasible, with 71.6% of participants completing the program, exceeding the feasibility threshold of 60%.
The coaching program covered various topics relevant to prostate cancer management, indicating that digital health coaching could be a valuable tool for improving patient engagement and self-management in this population.
A Pilot Feasibility Study of Digital Health Coaching for Men With Prostate Cancer.Handley, NR., Wen, KY., Gomaa, S., et al.[2022]
Breast cancer survivors using a health and wellness coaching app showed significant weight loss and a greater reduction in body mass index compared to those using a self-guided toolkit, indicating the app's effectiveness in promoting healthier lifestyles.
The app users also reported improvements in physical activity and dietary patterns, suggesting that access to live coaching can enhance adherence to wellness plans, although long-term app usage declined after 12 months.
Evaluation of a Mobile Health Intervention to Improve Wellness Outcomes for Breast Cancer Survivors.Cairo, J., Williams, L., Bray, L., et al.[2022]
This study will compare the effectiveness of a mobile health application combined with face-to-face rehabilitation versus the app alone in improving the Quality of Life for breast cancer survivors, involving women aged 25 to 75 with specific health criteria.
The primary outcome will be assessed after 8 weeks, focusing on Quality of Life, while secondary outcomes will include body composition, functionality, cognitive function, and mental health, highlighting the importance of both technology and professional support in cancer rehabilitation.
Integral strategy to supportive care in breast cancer survivors through occupational therapy and a m-health system: design of a randomized clinical trial.Lozano-Lozano, M., Martín-Martín, L., Galiano-Castillo, N., et al.[2022]

Citations

Clinical Trials DetailThis study intends to explore feasibility, acceptability, and outcomes related to the use of a digital health coaching intervention for individuals who have ...
Comprehensive Outcomes for After Cancer Health (COACH)This study intends to explore feasibility, acceptability, and outcomes related to the use of a digital health coaching intervention for individuals who have ...
Comprehensive Outcomes for After Cancer HealthThis study intends to explore feasibility, acceptability, and outcomes related to the use of a digital health coaching intervention for individuals who have ...
A Digital Coaching Intervention for Cancer Survivors With Job ...This study sought to evaluate return-to-work outcomes of a multidisciplinary intervention provided as routine employee support.
Med center reps study digital health coaching for cancer ...The COACH study is one of the first to investigate augmented coaching and an individual's health outcomes.
Evidence-based digital health interventions for breast ...We conducted an umbrella review to summarize the evidence on digital health interventions aimed at improving health-related outcomes for BCS.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security